Related Experiment Video

Updated: Jun 29, 2026

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by

Franco Silvestris1, Paola Cafforio, Monica De Matteo

  • 1Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Piazza Giulio Cesare 11, Bari, Italy. f.silvestris@dimo.uniba.it

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|October 3, 2008
PubMed
Abstract

Insights

Multiple myeloma impairs bone formation by inducing E4BP4, a repressor that inhibits osteoblast function. Restoring the COX-2 pathway can overcome this defect, highlighting E4BP4

Area of Science:

  • Bone Biology and Disease
  • Cancer Biology
  • Molecular Mechanisms of Osteogenesis

Background:

  • Multiple myeloma frequently causes bone disease, characterized by defective bone formation and repair.
  • Osteoblast dysfunction is a key pathogenetic mechanism underlying impaired osteogenesis in multiple myeloma.

Purpose of the Study:

  • To investigate the molecular mechanisms by which osteoblast function is suppressed in multiple myeloma.
  • To identify key regulatory pathways involved in defective bone formation during multiple myeloma progression.

Main Methods:

  • Microarray analysis to identify differentially expressed genes in osteoblasts co-cultured with myeloma cells.
  • Assessment of E4BP4 (a transcriptional repressor) function in parathyroid hormone-related protein (PTHrP)-stimulated osteoblasts.
  • Evaluation of Runx2 and Osterix (osteoblast transcriptional activators) RNA levels.
  • Investigation of the cyclooxygenase-2 (COX-2) pathway, prostaglandin E2 (PGE2) treatment, and E4BP4 silencing.
  • In vivo measurements of E4BP4, PTHrP, Osterix, and osteocalcin in patients with multiple myeloma bone disease.

Main Results:

  • E4BP4 was overexpressed in osteoblasts stimulated by PTHrP from myeloma cells and suppressed Runx2 and Osterix.
  • Silencing E4BP4 restored functional levels of Runx2 and Osterix.
  • Prostaglandin E2 treatment rescued Runx2 and Osterix activity in E4BP4-upregulated osteoblasts, confirming COX-2 pathway integrity is crucial.
  • In vivo studies confirmed E4BP4's role in down-regulating Osterix in myeloma patients with bone disease and elevated PTHrP.

Conclusions:

  • E4BP4 acts as an osteoblast transcriptional repressor in multiple myeloma bone disease.
  • E4BP4 inhibits key osteoblast activators Runx2 and Osterix.
  • The inhibitory effect of E4BP4 is correlated with increased parathyroid hormone-related protein (PTHrP) activity in myeloma.

More Related Videos

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.